Fig. 9From: Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancerCorrelation analysis between MTOR mutation and clinical characteristics. A Correlation of MTOR mutation frequency with MSI status. B Correlation of MTOR mutation frequency with age. C Correlation of MTOR mutation frequency with tumor location. D Correlation of MTOR mutation frequency with vascular invasion. E Correlation of MTOR mutation frequency with T stage. F Correlation of MTOR mutation frequency with N stage. G Correlation of MTOR mutation frequency with M stage. H Correlation of MTOR mutation frequency with clinicopathological stages. MSI, microsatellite instability; T, tumor; M, metastasis; N, nodeBack to article page